Impact of ALDH1A1 Expression in Intrahepatic Cholangiocellular Carcinoma

Konrad Kurowski, Melanie Christine Föll, Tilman Werner, Oliver Schilling, Martin Werner, Stefan Fichtner‐Feigl, Bertram Bengsch, Peter Bronsert, Philipp Holzner, Sylvia TimmeJournal of Cancer 2024 · DOI

TL;DR

This study investigates the role of ALDH1A1, a protein linked to cancer stem cells, in intrahepatic cholangiocarcinoma (iCC), a rare and aggressive liver cancer. They found that higher ALDH1A1 expression in both tumor and surrounding stromal cells is associated with better patient survival, particularly in women, suggesting it could be a valuable prognostic marker.

What Problem Does This Paper Address?

Intrahepatic cholangiocarcinoma (iCC) is a challenging cancer with limited treatment options and poor survival rates. Despite its increasing incidence, our understanding of its underlying mechanisms and reliable prognostic markers remains insufficient. ALDH1A1, a member of the aldehyde dehydrogenase superfamily, has been implicated in cancer stem cell populations and has shown conflicting prognostic roles in various cancers, including iCC. This paper aims to clarify ALDH1A1's prognostic significance in iCC, considering both tumor cells and the tumor microenvironment.

Methods

The researchers conducted a retrospective study using tissue microarrays (TMAs) from 69 iCC patients. They employed immunohistochemistry to assess ALDH1A1 expression, utilizing machine learning algorithms for objective and automated analysis of the stained tissue samples. Survival analyses were performed using Kaplan-Meier curves, log-rank tests, and Cox Proportional Hazards Models to evaluate the association between ALDH1A1 expression and patient outcomes.

Datasets

The study utilized a dataset of 69 intrahepatic cholangiocarcinoma (iCC) patient samples collected from the University Hospital Freiburg between 2000 and 2014. No new benchmark datasets were introduced.

Key Insights and Ideas

  • ALDH1A1 as a Favorable Prognosticator: Contrary to some previous associations with poor prognosis, this study found that high ALDH1A1 expression in iCC is linked to better overall survival. This challenges existing assumptions and highlights the context-dependent nature of ALDH1A1's role.
  • The Tumor Microenvironment Matters: The study emphasizes the importance of the tumor microenvironment by showing that ALDH1A1 expression in stromal cells (the supportive tissue around the tumor) also correlates with favorable survival. This suggests that interactions between tumor cells and their surroundings are crucial for patient outcomes.
  • Gender-Specific Differences: A particularly interesting finding is the more pronounced positive impact of ALDH1A1 expression on survival in female patients. This points towards potential sex-specific biological mechanisms in iCC that warrant further investigation.
  • AI-Assisted Pathology: The use of machine learning for immunohistochemical analysis offers a more objective and reproducible method compared to traditional manual scoring, potentially reducing inter-observer variability.

Key Results

  • High ALDH1A1 expression in both tumor cells (p = 0.0068) and stromal cells (p = 0.008) was significantly associated with longer overall patient survival.
  • In female patients, high ALDH1A1 expression in tumor cells (p = 0.0077) and stromal cells (p = 0.043) showed a significant correlation with prolonged survival.
  • No significant association was found between ALDH1A1 expression and survival in the male subgroup.
  • Multivariable Cox regression analysis confirmed that low ALDH1A1 expression was associated with an increased risk of death in both tumor (HR = 1.95) and stromal cells (HR = 2.23).
  • In females, low ALDH1A1 expression was linked to an increased risk of death (tumor: HR = 2.8; stroma: HR = 2.36).

Limitations and Future Work

The authors acknowledge that iCC is a rare disease, leading to a relatively small sample size (n=69). They emphasize the need for validation of their findings in larger, independent patient cohorts. Future research should focus on exploring the gender-specific biological mechanisms underlying ALDH1A1's role in iCC and investigating its potential as a predictive marker for targeted therapies, given the current lack of effective treatment options. The study also highlights the evolving landscape of oncological research, advocating for advanced techniques like AI-supported evaluation and a focus on the tumor microenvironment.

Summary updated

Abstract

<b>Background:</b> Intrahepatic cholangiocarcinoma (iCC) is a rare malignant liver tumor with limited therapeutic advancements. Despite its increasing global incidence knowledge of treatment options remains stagnant, leading to poor five-year patient survival rates and high recurrence post-surgery. ALDH1A1, a member of the ALDH superfamily, is associated with cancer stem cells and has conflicting reports regarding its prognostic role in iCC. This retrospective study analyzed 69 iCC patient samples from University Hospital Freiburg. Tissue microarrays (TMAs) were constructed, and ALDH1A1 expression was immunohistochemically assessed using machine learning algorithms. Script-based Survival analysis employed Kaplan-Meier curves, log-rank tests, and Cox Proportional Hazards Models. ALDH1A1 overexpression, both in tumor and stromal cells, correlates with favorable overall survival in iCC. Gender-specific analyses indicate a more pronounced effect in females. These findings suggest ALDH1A1 as a potential prognostic biomarker in iCC, warranting further validation in larger cohorts and exploration as a therapeutic target.
BibTeX
@article{kurowski2024impact,
  author = {Konrad Kurowski and Melanie Christine Föll and Tilman Werner and Oliver Schilling and Martin Werner and Stefan Fichtner‐Feigl and Bertram Bengsch and Peter Bronsert and Philipp Holzner and Sylvia Timme},
  title = {{Impact of ALDH1A1 Expression in Intrahepatic Cholangiocellular Carcinoma}},
  journal = {Journal of Cancer},
  year = {2024},
  doi = {10.7150/jca.99944},
}
Figure